AU2001279922A1 - Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof - Google Patents

Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof

Info

Publication number
AU2001279922A1
AU2001279922A1 AU2001279922A AU7992201A AU2001279922A1 AU 2001279922 A1 AU2001279922 A1 AU 2001279922A1 AU 2001279922 A AU2001279922 A AU 2001279922A AU 7992201 A AU7992201 A AU 7992201A AU 2001279922 A1 AU2001279922 A1 AU 2001279922A1
Authority
AU
Australia
Prior art keywords
nitrogen monoxide
precursor
metabolism
composition containing
iron complexing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001279922A
Other languages
English (en)
Inventor
Bernard Dugas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isocell SA
Original Assignee
Isocell SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isocell SA filed Critical Isocell SA
Publication of AU2001279922A1 publication Critical patent/AU2001279922A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001279922A 2000-07-27 2001-07-27 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof Abandoned AU2001279922A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0009883 2000-07-27
FR0009883A FR2812200B1 (fr) 2000-07-27 2000-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote ; et utilisations
PCT/FR2001/002469 WO2002009740A1 (fr) 2000-07-27 2001-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations

Publications (1)

Publication Number Publication Date
AU2001279922A1 true AU2001279922A1 (en) 2002-02-13

Family

ID=8852998

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001279922A Abandoned AU2001279922A1 (en) 2000-07-27 2001-07-27 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof

Country Status (8)

Country Link
US (1) US6984624B2 (enExample)
EP (1) EP1303296B1 (enExample)
JP (1) JP2004520264A (enExample)
AT (1) ATE292978T1 (enExample)
AU (1) AU2001279922A1 (enExample)
DE (1) DE60110084D1 (enExample)
FR (1) FR2812200B1 (enExample)
WO (1) WO2002009740A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
WO2005025399A2 (en) 2003-09-12 2005-03-24 Or-Nim Medical Ltd. Noninvasive optical monitoring of region of interest
DE602004001972T2 (de) * 2004-04-23 2007-09-06 Abb Research Ltd. Modell und Regelung eines Müllverbrennungsverfahrens
ZA200702421B (en) * 2004-10-08 2008-09-25 Unilever Plc Iron complex for use in the treatment and/or prevention of nutritional disorders
EP1867330A4 (en) * 2005-03-30 2012-01-25 Kyowa Hakko Bio Co Ltd METHOD FOR IMPROVING THE STORAGE STABILITY OF A SUBSTANCE
US20090202613A1 (en) * 2008-02-11 2009-08-13 Tabatchnick Fine Foods, Inc. Nutritionally Enhanced Therapeutic Preventative Food Supplement and Method of Making Same
WO2009101789A1 (ja) * 2008-02-14 2009-08-20 Morinaga Milk Industry Co., Ltd. 卵巣機能改善剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726768B1 (en) * 1993-11-02 2000-05-17 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, Department of Health and Human Services Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury
US5827729A (en) * 1996-04-23 1998-10-27 Advanced Tissue Sciences Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue
AU6307698A (en) * 1997-02-03 1998-08-25 Pharming Bv Useful properties of human lactoferrin and variants thereof

Also Published As

Publication number Publication date
WO2002009740A1 (fr) 2002-02-07
EP1303296B1 (fr) 2005-04-13
JP2004520264A (ja) 2004-07-08
ATE292978T1 (de) 2005-04-15
US20040033945A1 (en) 2004-02-19
EP1303296A1 (fr) 2003-04-23
DE60110084D1 (de) 2005-05-19
US6984624B2 (en) 2006-01-10
FR2812200A1 (fr) 2002-02-01
FR2812200B1 (fr) 2003-01-03

Similar Documents

Publication Publication Date Title
EP1339413A4 (en) PHOSPHATE DERIVATIVE COMPLEXES
AU7931301A (en) Method of using diketopiperazines and composition containing them
GB0109690D0 (en) Improvements in or relating to compositions
WO1999059640A3 (en) Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
NO20015991D0 (no) Bisykliske polyaminoacid-metallkomplekser, fremgangsmåter for fremstilling av disse og anvendelse i medisinsk billeddannelse
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
MY134559A (en) Lactam compound to inhibit beta-amyloid peptide release or synthesis
WO1999043355A3 (en) Formulations containing oxaliplatin
WO2007035757A3 (en) Composition and method for treating iron deficiency anemia
AU4871797A (en) Magnesium (-)hydroxycitrate, preparation process, uses and compositions, in particular pharmaceutical compositions, containing it
AU2496199A (en) Copolymer compositions for oral delivery
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
CA2481593A1 (en) Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin
HUP0204294A2 (hu) Antimikrobiális izzadásgátló termék
AU2001279922A1 (en) Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof
NZ319138A (en) Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi
EP1097646A3 (en) Modified milk powder composition
MXPA03001287A (es) Uso de complejos metalicos conteniendo perfluoroalquilo como medios de contraste en imagenes rm para la representacion de placas, tumores y necrosis.
MY124078A (en) Eletriptan hydrobromide monohydrate
WO2004037907A3 (en) Luminescent metal ion complexes
MXPA02005045A (es) Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer.
EP1038524A4 (en) L-THREONATE IRON, PHARMACEUTICAL COMPOSITION AND USE FOR IMPROVEMENT AND TREATMENT OF ANEMIA IN PEOPLE
MXPA04005942A (es) Composiciones y metodos de sintaxina 3.
GB9923858D0 (en) Antimicrobial compositions
EP1462113A4 (en) CELL GROWTH INHIBITORS WITH ANTI-PEPT ANTIBODIES